These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2254559)

  • 1. Antiarrhythmic treatment and myocardial infarction.
    Keung EC
    J Am Coll Cardiol; 1990 Dec; 16(7):1719-21. PubMed ID: 2254559
    [No Abstract]   [Full Text] [Related]  

  • 2. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
    Gambhir DS
    Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817
    [No Abstract]   [Full Text] [Related]  

  • 3. Amiodarone: a late comer.
    Futterman LG; Lemberg L
    Am J Crit Care; 1997 May; 6(3):233-9. PubMed ID: 9131203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of antiarrhythmic agents after myocardial infarction with special reference to the EMIAT and CAMIAT trials of amiodarone. European Myocardial Infarct Amiodarone Trial. Canadian Amiodarone Myocardial Infarction Trial.
    Jafri SM; Borzak S; Goldberger J; Gheorghiade M
    Prog Cardiovasc Dis; 1998; 41(1):65-70. PubMed ID: 9717860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS).
    Burkart F; Pfisterer M; Kiowski W; Follath F; Burckhardt D
    J Am Coll Cardiol; 1990 Dec; 16(7):1711-8. PubMed ID: 2254558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should post-infarction asymptomatic ventricular arrhythmias be treated? The need for caution.
    Sleight P
    Eur Heart J; 1995 Jul; 16 Suppl E():49. PubMed ID: 8542884
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of arrhythmias after myocardial infarction in the post-CAST era.
    Camm AJ; Kautzner J
    Can J Cardiol; 1996 Apr; 12 Suppl B():9B-19B; discussion 27B-28B. PubMed ID: 8616727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Death is still a death. Does it matter if the cause is myocardial infarction or arrhythmia?].
    Werkö L
    Lakartidningen; 1998 Jan; 95(4):246-8. PubMed ID: 9469947
    [No Abstract]   [Full Text] [Related]  

  • 9. The amiodarone trials.
    Julian DG
    Eur Heart J; 1997 Sep; 18(9):1361-2. PubMed ID: 9458435
    [No Abstract]   [Full Text] [Related]  

  • 10. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
    Malik M; Camm AJ
    Lancet; 1997 Jun; 349(9067):1767-8. PubMed ID: 9193398
    [No Abstract]   [Full Text] [Related]  

  • 11. Amiodarone and mortality in CHF and post-MI.
    Zamorski M
    J Fam Pract; 1998 Mar; 46(3):196-7. PubMed ID: 9519009
    [No Abstract]   [Full Text] [Related]  

  • 12. The SWORD of Damocles.
    Sanderson J
    Lancet; 1996 Jul; 348(9019):2-3. PubMed ID: 8691925
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective controlled randomized trial of prophylactic antiarrhythmic therapy in postmyocardial infarction patients with asymptomatic ventricular arrhythmias--study design and initial results.
    Pfisterer M; Burkart F; Follath F; Burckhardt D
    Clin Cardiol; 1988 Mar; 11(3 Suppl 2):II41-5. PubMed ID: 3078156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of sudden death with antiarrhythmic agents after myocardial infarction].
    Raviele A; Gasparini G
    G Ital Cardiol; 1992 Apr; 22(4):463-7. PubMed ID: 1385246
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiarrhythmic trials: a decade of growth.
    Kanjwal MY
    Indian Heart J; 1998; 50(3):277-84. PubMed ID: 9753848
    [No Abstract]   [Full Text] [Related]  

  • 16. Meta-analysis of empirical long-term antiarrhythmic therapy after myocardial infarction.
    Hine LK; Laird NM; Hewitt P; Chalmers TC
    JAMA; 1989 Dec; 262(21):3037-40. PubMed ID: 2509746
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
    Cairns JA; Connolly SJ; Roberts R; Gent M
    Lancet; 1997 Mar; 349(9053):675-82. PubMed ID: 9078198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary prevention after myocardial infarction with class III antiarrhythmic drugs.
    Ceremuzyński L
    Am J Cardiol; 1993 Nov; 72(16):82F-86F. PubMed ID: 8237835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.
    Julian DG; Camm AJ; Frangin G; Janse MJ; Munoz A; Schwartz PJ; Simon P
    Lancet; 1997 Mar; 349(9053):667-74. PubMed ID: 9078197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arrhythmia as risk factor].
    Internist (Berl); 1997 Feb; 38(2 Suppl Risikofakt):1-8. PubMed ID: 9330651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.